<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-99802</identifier>
<setSpec>1888-4008</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Clinical relevance of placental-like alkaline phosphatase isoenzyme as a germ cell tumour marker</dc:title>
<dc:description xml:lang="en">Background and purpose. To determine the clinical relevance of placental-like alkaline phosphatase isoenzyme (PLAP-like) as a marker for germ cell tumours (GCT). Patients and methods. We report the behaviour of this isoenzyme in two patients; 1) A Child with an intracranial germinoma in the pineal region who showed 75% of PLAP-like activity at onset (normal value: 0%), with the rest of the tumour markers being negative, and 2) A girl with a stage I ovarian immature teratoma who had an elevated alpha-fetoprotein (AFP), 197ng/mL, PLAP-like 5.1%, at onset and 0.7% at tumour recurrence two years later. PLAP-like was determined by assessing the remaining activity after heat denaturation of the serum. Discussion and conclusions. PLAP-like constituted the only specific marker in the case of the pineal cell germ tumour, which justifies its use in association with neuroimaging studies in the diagnosis of cranial tumours. At follow-up analysis, PLAP-like was also critical since it confirmed the good response to treatment in the first case, while in the second one, it was the only marker to complement the assessment of tumour recurrence. We believe that this isoenzyme analysis is of relevance as a complementary marker in GCT (AU)</dc:description>
<dc:creator>Vílchez Aguilera, Juan Antonio</dc:creator>
<dc:creator>Parra Pallarés, Soledad</dc:creator>
<dc:creator>Martínez Hernández, Pedro</dc:creator>
<dc:creator>Avilés Plaza, Francisco</dc:creator>
<dc:creator>Martínez-Lage Sánchez, Juan F</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Fundamento y objetivo. Justificar la importancia clínica de la determinación del isoenzima de fosfatasa alcalina (PLAP-like) como marcador en tumores de células germinales (TCG). Pacientes y métodos. Se documentan dos casos clínicos observando el comportamiento de este isoenzima: 1) Niño con germinoma intracraneal en región pineal, 75% de actividad de PLAP-like al inicio (valor normal: 0%), resto de marcadores tumorales negativos, y 2) Niña con teratoma inmaduro de ovario estadio I, elevación de la alfafetoproteína (AFP), 197ng/mL; PLAP-like 5,1% al inicio y 0,7% en recidiva tumoral tras dos años. Se determina PLAP-like valorando la actividad remanente tras termodesnaturalización sérica. Discusión y conclusiones. PLAP-like se comporta como único marcador específico en el primer caso de tumor germinal pineal que justifica su utilidad junto a pruebas de imagen en el diagnóstico de tumores de localización craneal. En el seguimiento, también es crítico el análisis dado que constata la buena respuesta al tratamiento en el primer caso, y en el segundo caso clínico, es el único marcador que complemente la valoración de la recidiva. Concluimos en la relevancia del análisis de este isoenzima como marcador complementario en TCG (AU)</dc:description>
<dc:source>Rev. lab. clín;5(1): 44-48, ene.-mar. 2012.</dc:source>
<dc:identifier>ibc-99802</dc:identifier>
<dc:title xml:lang="es">Isoenzima de fosfatasa alcalina placental-like, importancia clínica como marcador en tumores de tipo germinal</dc:title>
<dc:subject>^d24373^s22001</dc:subject>
<dc:subject>^d7694</dc:subject>
<dc:subject>^d14102^s22012</dc:subject>
<dc:subject>^d24373^s22002</dc:subject>
<dc:subject>^d2694</dc:subject>
<dc:subject>^d14102^s22016</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d3965</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d471</dc:subject>
<dc:subject>^d471^s22065</dc:subject>
<dc:subject>^d471^s22044</dc:subject>
<dc:subject>^d31880^s22016</dc:subject>
<dc:subject>^d471^s22079</dc:subject>
<dc:type>article</dc:type>
<dc:date>201203</dc:date>
</metadata>
</record>
</ibecs-document>
